Dark Forest Capital Management LP Biocryst Pharmaceuticals Inc Transaction History
Dark Forest Capital Management LP
- $634 Million
- Q4 2024
A detailed history of Dark Forest Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Dark Forest Capital Management LP holds 29,693 shares of BCRX stock, worth $268,721. This represents 0.04% of its overall portfolio holdings.
Number of Shares
29,693
Previous 49,376
39.86%
Holding current value
$268,721
Previous $375,000
40.53%
% of portfolio
0.04%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding BCRX
# of Institutions
279Shares Held
169MCall Options Held
930KPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA21.9MShares$198 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$181 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$107 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$82.2 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$73.7 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.68B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...